There are 15 iohexol and seven iodixanol contrast media solutions available, according to GE.
About 10 months ago, a COVID-19 lockdown curbed production at GE Healthcare’s factory in Shanghai, leading to a monthslong shortage of contrast media. The supply issue was projected to last through June before being bumped to September.
The shortage left many in limbo as CT dye is used in millions of tests every year to diagnose cancer and other diseases.
The Shanghai plant has been operating at 100 percent since this summer, according to GE.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.